Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
Mar. 31, 2024	Mar. 31, 2023
Revenues	$ 145,639	$ 105,984
Cost of revenues	110,356	97,463
Gross profit	35,283	8,521
Operating expenses:
Research and development	7,991	8,966
Selling, general and administrative	31,600	28,700
Amortization of acquisition related intangibles	2,152	2,746
Change in fair value of contingent consideration	4,922	70
Restructuring	(14)	1,048
Total operating expenses	46,651	41,530
Operating loss	(11,368)	(33,009)
Interest income, net	1,302	252
China dissolution	0	(1,921)
Other expense, net	(736)	(148)
Loss before income tax expense	(10,802)	(34,826)
Income tax expense	309	215
Net loss	$ (11,111)	$ (35,041)
Net loss per common share
Basic (in dollars per share)	$ (0.37)	$ (1.26)
Diluted (in dollars per share)	$ (0.37)	$ (1.26)
Weighted average number of common shares outstanding
Basic (in shares)	29,825	27,848
Diluted (in shares)	29,825	27,848

The amount of expense recognized in the current period that reflects the allocation of capitalized costs associated with acquisition of business. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.

Name:	us-gaap_AmortizationOfAcquisitionCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.